News

Ant International Elevates Digital Payments with AI Innovations

Ant International Elevates Digital Payments with AI Innovations

Ant International Enhances Digital Payment Solutions

Ant International, a key player in the global digital payment and financial technology sphere, has outlined a transformative journey through 2024 with significant advancements across its four primary sectors: Alipay+, Antom, WorldFirst, and Embedded Finance. The company is capitalizing on growth opportunities and technological evolution to strengthen its market position.

Expansion of Alipay+

Central to Ant International's strategy is Alipay+, which has made substantial strides in enhancing its wallet-based payment and digitalization offerings. This initiative further develops the synergy between its other fintech services, WorldFirst and Antom, fostering a cohesive ecosystem.

Partnerships and Merchant Connections

Alipay+ is leading the charge in integrating with 35 premier mobile payment partners, including an array of e-wallets and banking applications. This connects an impressive network of over 90 million merchants across 66 markets, serving approximately 1.6 billion user accounts. The partnerships with various national QR schemes, such as those in Singapore and Malaysia, represent a significant move towards financial inclusivity.

Empowering Small Enterprises

Notably, more than 90% of Alipay+ affiliated merchants are small and medium enterprises (SMEs). The focus remains on facilitating an inclusive digital transformation, driving substantial growth in cross-border transactions that have reportedly tripled year on year.

Innovations from Antom

Antom, recognized for its specialized merchant payment solutions, is also witnessing remarkable growth. The total payment volume for its services has nearly doubled within the first eleven months of 2024 compared to the same timeframe in 2023.

Streamlined Payment Solutions

Antom's innovations extend to enhancing payment processing capabilities across multiple channels. Its card processing volume has increased tenfold, offering reliable authorization rates to enterprise clients. Noteworthy technology implementations like the Antom Copilot have drastically cut down integration times, marking a revolutionary improvement in operational efficiency.

User-Centric Features

Additionally, Antom EasySafePay simplifies user interactions by allowing seamless digital wallet payments without redirecting users away from the merchant’s checkout. This advancement promises to boost the success rate of transactions significantly.

WorldFirst's Remarkable Trajectory

A major highlight for Ant International in 2024 is WorldFirst, which has reached an annual total payment volume of US$100 billion, marking an incredible fourfold increase since its acquisition. This achievement positions WorldFirst as a leading entity in the digital payment sector for cross-border functionalities.

Expanding Global Support

WorldFirst has served over one million SMEs worldwide, accumulating a total transaction volume exceeding US$300 billion. The company's dedication to enhancing service diversity and geographic footprint continues to show promising growth trends.

Empowering Embedded Finance

The Embedded Finance division at Ant International leverages cutting-edge AI and blockchain technologies to build secure, seamless financial solutions. This offering addresses a wide array of client needs, from risk modeling to liquidity management and targeted lending solutions.

AI-Driven Financial Management

One remarkable innovation is the Time-Series Transformer AI FX Model developed by Platform Tech. This model assists multinational merchants in optimizing treasury management, providing accurate predictions on real-time local currency requirements, and driving substantial cost reductions.

Comprehensive Financing Options

Ant International's credit services via the ANEXT Bank have expanded significantly, particularly in emerging markets like Bangladesh and Indonesia. The launch of bettr has allowed underserved micro-businesses and individuals to access credit services without collateral, supported by fair credit ratings.

Looking Ahead

As Ant International sets its sights on the future, the company emphasizes its commitment to empowering SMEs across borders while embracing AI-powered technologies and fostering inclusive financial ecosystems. By enhancing collaboration with public and private sectors, the company aims to push the envelope on innovative financial solutions.

About Ant International

Headquartered in Singapore, Ant International is dedicated to shaping the future of global commerce through advanced digital innovations. The company collaborates closely with partners across industries to offer a diverse suite of tech-driven digital payment solutions, helping businesses of all sizes achieve their growth ambitions.

Frequently Asked Questions

What is Ant International known for?

Ant International is a leading digital payment and financial technology provider known for its solutions across multiple sectors, including payment processing and financial services.

How does Alipay+ benefit merchants?

Alipay+ connects merchants to a global network of over 1.6 billion users, enabling them to reach new customers and expand their market presence.

What innovations has Antom introduced?

Antom has launched several tech-driven solutions to enhance payment processing efficiency and user experience, like Antom Copilot and EasySafePay.

What milestones has WorldFirst achieved?

WorldFirst has surpassed a total payment volume of US$100 billion in 2024, significantly growing its client base and transaction volumes since its acquisition.

What is the focus of Embedded Finance?

The Embedded Finance division focuses on creating seamless financing solutions using AI and blockchain technology to serve small businesses and individuals.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 128

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 337

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 222

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 202

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 206

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 531

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 222

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 130

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 218

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading

Top 5 Most Recently Viewed Articles

Elegoo's Empowering Step for Women in 3D Printing Ecosystem

Updated Category News Views 125

Elegoo Launches Empowering Initiative for Women Elegoo, a leading innovator in global smart manufacturing, is excited to announce the launch of its first women empowerment initiative, titled "ELEGOO With Her." This initiative is set to make waves at the prominent Formnext 2024 event. The program's mission is to empower women and girls by equipping them with essential...

Continue Reading
Martin Marietta to Host Q3 Earnings Call: Key Details Revealed

Updated Category News Views 105

Martin Marietta's Upcoming Earnings Conference Call Martin Marietta Materials, Inc. (NYSE: MLM) is gearing up to host its earnings conference call for the third quarter. Scheduled for later this month, this event offers investors a chance to gain insights into the company’s recent performance and financial outlook. Date and Time of the Conference Call The earnings call...

Continue Reading
Eastern Bankshares Achieves Growth After Merger with Cambridge Trust

Updated Category News Views 214

Eastern Bankshares Reports Impressive Growth Following Merger Eastern Bankshares, Inc. (NASDAQ: EAST) recently shared exciting updates during its third quarter earnings call, highlighting significant advancements following its merger with Cambridge Trust. This strategic move has firmly established Eastern as the largest community bank in its region, encompassing Eastern...

Continue Reading
Important Details for Baltic Horizon Fund’s Upcoming Meeting

Updated Category News Views 94

Invitation to the Extraordinary General Meeting At the request of a unitholder representing over 1/10 of all votes, Northern Horizon Capital AS warmly invites all Baltic Horizon Fund unit-holders, alongside holders of Swedish Depositary Receipts (SDRs), collectively known as "Investors," to participate in a significant General Meeting of the Baltic Horizon Fund. This...

Continue Reading
Investigation into Confluent, Inc. Securities Practices

Updated Category News Views 210

Pomerantz Law Firm Investigates Confluent, Inc. Securities Issues Pomerantz LLP is investigating claims raised on behalf of investors of Confluent, Inc. (NASDAQ: CFLT). This investigation focuses on whether Confluent and its leadership have engaged in securities fraud or unlawful business practices. Investors should take this opportunity to closely examine their options....

Continue Reading